Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · T-lymphoblastic Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Liang Wang, Beijing, Beijing Municipality, China
Contact: Study coordinator (Liang Wang, M.D.) · wangliangtrhos@126.com · +8615001108693
Contact: Principal Investigator (Liang Wang, M.D.)

Study leads

Liang Wang, M.D.
Principal Investigator
Beijing Tongren Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea

Registry of Older Patients With Cancer

Chronic Myeloproliferative Disorders · Cognitive/Functional Effects · Leukemia

Abroad (travel likely)Recruiting

Boone, United States · Chapel Hill, United States

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Chronic Myeloproliferative Disorders · Leukemia · Lymphoma

Abroad (travel likely)Recruiting

Chapel Hill, United States

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States